CBUS · Cibus, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-08 | Wichner Craig |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest as to 25% on each of the first four anniversaries of the grant date. |
Class A Common Stock
|
894,309 |
| 2026-06-08 | Wichner Craig |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest as to 25% on each of the first four anniversaries of the grant date. |
Stock Option (Right-to-Buy)
|
1,047,620 |
| 2026-06-02 | Wichner Craig |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full subject to the Director's continued service, on the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Stock Option (Right-to-Buy)
|
77,586 |
| 2026-06-02 | RIGGS RORY B |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Stock Option (Right-to-Buy)
|
77,586 |
| 2026-06-02 | Lehmann Jean-Pierre Jules |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Class A Common Stock
|
64,748 |
| 2026-06-02 | Finn Mark Terrence |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Stock Option (Right-to-Buy)
|
77,586 |
| 2026-06-02 | Box Kimberly Ann |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (a) the first anniversary of the grant date and (b) the date of the Company's next annual meeting of shareholders. |
Stock Option (Right-to-Buy)
|
77,586 |
| 2026-06-02 | Urban Thomas |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Class A Common Stock
|
64,748 |
| 2026-06-02 | Moretti August J |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders. |
Stock Option (Right-to-Buy)
|
77,586 |
| 2026-06-02 | Prante Gerhard |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of the shareholders. |
Class A Common Stock
|
64,748 |
| 2026-04-24 | Gocal Gregory Francis William |
Chief Scientific Officer & EVP |
Award↑
|
Class A Common Stock
|
57,000 |
| 2026-04-24 | Gocal Gregory Francis William |
Chief Scientific Officer & EVP |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. |
Stock Option (Right-to-Buy)
|
114,000 |
| 2026-04-24 | Beetham Peter |
Director, Interim CEO, Pres & COO |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. |
Stock Option (Right-to-Buy)
|
390,000 |
| 2026-04-24 | Beetham Peter |
Director, Interim CEO, Pres & COO |
Award↑
|
Class A Common Stock
|
195,000 |
| 2026-04-24 | Stokes Jason |
CLO, Gen Csl & Secy |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant |
Stock Option (Right-to-Buy)
|
114,000 |
| 2026-04-24 | Broos Carlo |
CFO |
Award↑
|
Class A Common Stock
|
57,000 |
| 2026-04-24 | Sauer Noel |
Sr VP, Research |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. |
Stock Option (Right-to-Buy)
|
76,000 |
| 2026-04-24 | Stokes Jason |
CLO, Gen Csl & Secy |
Award↑
|
Class A Common Stock
|
57,000 |
| 2026-04-24 | Broos Carlo |
CFO |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. |
Stock Option (Right-to-Buy)
|
114,000 |
| 2026-04-24 | Urban Thomas |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest as to 100% on the date of the grant |
Stock Option (Right-to-Buy)
|
9,094 |
| 2026-04-24 | Sauer Noel |
Sr VP, Research |
Award↑
|
Class A Common Stock
|
38,000 |
| 2026-03-30 | Broos Carlo |
CFO |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.81 to $2.05, inclusive. |
Class A Common Stock
|
3,676 |
| 2026-03-30 | Stokes Jason |
CLO, Gen Csl & Secy |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.81 to $1.88, inclusive. |
Class A Common Stock
|
3,695 |
| 2026-03-30 | Sauer Noel |
Sr VP, Research |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.815 to $1.90, inclusive. |
Class A Common Stock
|
1,763 |
| 2026-03-30 | Gocal Gregory Francis William |
Chief Scientific Officer & EVP |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.795 to $1.86, inclusive. |
Class A Common Stock
|
8,954 |
| 2026-03-30 | Beetham Peter |
Director, Interim CEO, Pres & COO |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.81 to $2.10, inclusive. |
Class A Common Stock
|
16,112 |
| 2026-02-19 | Stokes Jason |
CLO, Gen Csl & Secy |
Tax↓
|
Class A Common Stock
|
4,795 |
| 2026-01-29 | RIGGS RORY B |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
On January 29, 2026, Cibus, Inc. (the "Issuer") entered into an Underwriting Agreement (the "Underwriting Agreement") in connection with a firm commitment underwritten public offering (the "Offering"), which closed on January 30, 2026. The reporting person purchased 333,333 shares of Class A Common Stock in the Offering at the public offering price of $1.50 per share. The transaction was approved by the Issuer's board of directors in accordance with Rule 16b-3. |
Class A Common Stock
|
333,333 |
| 2026-01-29 | Lehmann Jean-Pierre Jules |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
On January 29, 2026, Cibus, Inc. (the "Issuer") entered into an Underwriting Agreement (the "Underwriting Agreement") in connection with a firm commitment underwritten public offering (the "Offering"), which closed on January 30, 2026. The reporting person purchased 666,666 shares of Class A Common Stock in the Offering at the public offering price of $1.50 per share. The transaction was approved by the Issuer's board of directors in accordance with Rule 16b-3. |
Class A Common Stock
|
666,666 |
| 2025-11-11 | Stokes Jason |
CLO, Gen Csl & Secy |
Tax↓
|
Class A Common Stock
|
3,519 |
| 2025-11-11 | Broos Carlo |
CFO |
Tax↓
|
Class A Common Stock
|
1,496 |
| 2025-11-11 | Sauer Noel |
Sr VP, Research |
Tax↓
|
Class A Common Stock
|
1,834 |
| 2025-11-05 | Wichner Craig |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
Subject to the Director's continued service, on the earlier of (a) the first anniversary of the Grant Date and (b) the date of the Company's next annual meeting of the shareholders following the Grant Date. Notwithstanding the foregoing, any unexpired, unvested Option will become vested as to the total number of shares underlying the Option if a Triggering Event (as defined in the Cibus, Inc. 2017 Omnibus Incentive Plan (the "Plan")) occurs and the Director provides continued service through the date of such Triggering Event. |
Stock Option (Right-to-Buy)
|
45,627 |
| 2025-09-11 | Box Kimberly Ann |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
Subject to the Director's continued service, on the earlier of (a) the first anniversary of the Grant Date and (b) the date of the Company's next annual meeting of the shareholders following the Grant Date. Notwithstanding the foregoing, any unexpired, unvested Option will become vested as to the total number of shares underlying the Option if a Triggering Event (as defined in the Cibus, Inc. 2017 Omnibus Incentive Plan (the "Plan")) occurs and the Director provides continued service through the date of such Triggering Event. |
Stock Option (Right-to-Buy)
|
54,722 |
| 2025-06-13 | Sauer Noel |
Sr VP, Research |
Sell↓
|
Class A Common Stock
|
4 |
| 2025-06-09 | RIGGS RORY B |
Director |
Exercise↓
Filing footnotes — Pre-Funded Warrant (right to buy) (Direct)
Pre-funded warrants to purchase Class A Common Stock held by the reporting person have no expiration date. |
Pre-Funded Warrant (right to buy)
|
50,000 |
| 2025-06-09 | RIGGS RORY B |
Director |
Exercise↑
|
Class A Common Stock
|
4,000,000 |
| 2025-06-09 | RIGGS RORY B |
Director |
Exercise↑
|
Class A Common Stock
|
50,000 |
| 2025-06-09 | RIGGS RORY B |
Director |
Exercise↓
Filing footnotes — Pre-Funded Warrant (right to buy) (Direct)
Pre-funded warrants to purchase Class A Common Stock held by the reporting person have no expiration date. |
Pre-Funded Warrant (right to buy)
|
4,000,000 |
| 2025-06-05 | RIGGS RORY B |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
On June 5, 2025, Cibus, Inc. (the "Issuer") entered into a Securities Purchase Agreement (the "Purchase Agreement") with Rory Riggs, the Chairman of the Company's Board of directors, in connection with a public offering conducted on a reasonable "best efforts" basis (the "Offering"). Pursuant to the Purchase Agreement, the Issuer agreed to issue and sell to Mr. Riggs 5,714,286 shares of Class A Common Stock, par value $0.0001 per share, at the public offering price of $1.75 per share. The Offering is expected to be fully consummated on or about June 9, 2025. The transaction was approved by the Issuer's board of directors in accordance with Rule 16b-3. Reflects corrections with respect to 20,891 shares of Class A Common Stock that were previously reported as attributable directly to the reporting person that are instead held indirectly through the Rory Riggs Family Trust. |
Class A Common Stock
|
5,714,286 |
| 2025-05-22 | Finn Mark Terrence |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vet in full, subject to the Director's continued service, on the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of the shareholders |
Stock Option (Right-to-Buy)
|
39,301 |
| 2025-05-22 | Prante Gerhard |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of the shareholders |
Class A Common Stock
|
32,490 |
| 2025-05-22 | RIGGS RORY B |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of the shareholders |
Stock Option (Right-to-Buy)
|
39,301 |
| 2025-05-22 | Lehmann Jean-Pierre Jules |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders |
Class A Common Stock
|
32,490 |
| 2025-05-22 | Walker Keith Allen |
Director |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of the shareholders |
Stock Option (Right-to-Buy)
|
39,301 |
| 2025-05-22 | Moretti August J |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders |
Stock Option (Right-to-Buy)
|
39,301 |
| 2025-03-24 | Stokes Jason |
CLO, Gen Csl & Secy |
Award↑
|
Class A Common Stock
|
28,250 |
| 2025-03-24 | Gocal Gregory Francis William |
Chief Scientific Officer & EVP |
Award↑
|
Class A Common Stock
|
60,000 |
| 2025-03-24 | Beetham Peter |
Director, Interim CEO, Pres & COO |
Award↑
|
Class A Common Stock
|
125,500 |
| 2025-03-24 | Gocal Gregory Francis William |
Chief Scientific Officer & EVP |
Award↑
Filing footnotes — Stock Option (Right-to-Buy) (Direct)
Options vest substantially equally each month until March 24, 2029 |
Stock Option (Right-to-Buy)
|
119,500 |